Literature DB >> 10448488

Tuberculosis of the central nervous system.

R K Garg1.   

Abstract

Tuberculous involvement of the brain and spinal cord are common neurological disorders in developing countries and have recently shown a resurgence in developed ones. Tuberculous meningitis is an important manifestation and is associated with high morbidity and mortality. Diagnosis is based on clinical features, cerebrospinal fluid changes, and imaging characteristics. Bacteriological confirmation is not possible in all cases as serological tests do not have sufficient sensitivity and specificity. The polymerase chain reaction shows promise for the future. Appropriate chemotherapeutic agents should be administered as early as possible, although there is no unanimity concerning chemotherapeutic regimens or optimal duration of treatment. The patient's clinical stage at presentation is the most important prognostic factor. The role of corticosteroids is controversial but they should be administered to all patients presenting in stage III. Surgical procedures are directed at management of the hydrocephalus. Focal lesions, intracranial tuberculomas, and tuberculous abscesses, are usually located in cerebral or cerebellar hemispheres, uncommonly in brainstem and very rarely in spinal cord. They do not usually require surgical intervention and respond well to antituberculous treatment, along with corticosteroids.

Entities:  

Mesh:

Year:  1999        PMID: 10448488      PMCID: PMC1741157          DOI: 10.1136/pgmj.75.881.133

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  48 in total

1.  New approaches to the rapid diagnosis of tuberculous meningitis.

Authors:  T M Daniel
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

2.  Symptomatic intracranial tuberculoma developing during treatment of tuberculosis: a report of 10 patients and review of the literature.

Authors:  R Teoh; M J Humphries; G O'Mahony
Journal:  Q J Med       Date:  1987-05

3.  Tuberculous encephalopathy with and without meningitis. Clinical features and pathological correlations.

Authors:  P M Udani; D K Dastur
Journal:  J Neurol Sci       Date:  1970-06       Impact factor: 3.181

4.  Spinal meningitides with radiculo-myelopathy. 1. Clinical and radiological features.

Authors:  N H Wadia; D K Dastur
Journal:  J Neurol Sci       Date:  1969 Mar-Apr       Impact factor: 3.181

5.  Tuberculous meningitis.

Authors:  A Molavi; J L LeFrock
Journal:  Med Clin North Am       Date:  1985-03       Impact factor: 5.456

6.  Tuberculous meningitis.

Authors:  D H Kennedy; R J Fallon
Journal:  JAMA       Date:  1979-01-19       Impact factor: 56.272

Review 7.  Diagnosis and neurosurgical treatment of tuberculous disease of the CNS.

Authors:  H M Dastur
Journal:  Neurosurg Rev       Date:  1983       Impact factor: 3.042

8.  Rapid diagnosis of tuberculous meningitis by latex particle agglutination.

Authors:  E Krambovitis; M B McIllmurray; P E Lock; W Hendrickse; H Holzel
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

9.  Intracranial tuberculoma and the CT scan.

Authors:  U S Vengsarkar; R P Pisipaty; B Parekh; V G Panchal; M N Shetty
Journal:  J Neurosurg       Date:  1986-04       Impact factor: 5.115

Review 10.  CNS tuberculosis.

Authors:  J R Sheller; R M Des Prez
Journal:  Neurol Clin       Date:  1986-02       Impact factor: 3.806

View more
  74 in total

1.  Improving the bacteriological diagnosis of tuberculous meningitis.

Authors:  Guy E Thwaites; Tran Thi Hong Chau; Jeremy J Farrar
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

2.  Concurrent intracerebral and intramedullary spinal tuberculomas in an immunocompetent individual.

Authors:  Srikanth Prasad; Muralidhar Varma; Sudha Vidyasagar
Journal:  BMJ Case Rep       Date:  2015-09-11

3.  Hypothalamic chiasmatic tuberculoma mimicking glioma.

Authors:  Chinmaya Dash; Raghav Singla; Kanwaljeet Garg; Vivek Tandon; Bhawani Shankar Sharma
Journal:  Childs Nerv Syst       Date:  2015-12-12       Impact factor: 1.475

4.  Tuberculosis of the neuromusculoskeletal system: a review of two cases presenting as chiropractic patients.

Authors:  Ismat Kanga; John A Taylor; Craig Jacobs; Geoff Outerbridge
Journal:  J Can Chiropr Assoc       Date:  2015-03

Review 5.  Management of intracranial pressure in tuberculous meningitis.

Authors:  J M K Murthy
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 6.  [Neurotuberculosis: a continuing clinical challenge].

Authors:  B-M Mackert; J Conradi; C Loddenkemper; F K H van Landeghem; R Loddenkemper; R Ignatius; T Schneider
Journal:  Nervenarzt       Date:  2008-02       Impact factor: 1.214

7.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

Review 8.  Invasion of the central nervous system by intracellular bacteria.

Authors:  Douglas A Drevets; Pieter J M Leenen; Ronald A Greenfield
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Unusual forms of spinal tuberculosis.

Authors:  Jaco du Plessis; Savvas Andronikou; Salomine Theron; Nicky Wieselthaler; Murray Hayes
Journal:  Childs Nerv Syst       Date:  2007-11-07       Impact factor: 1.475

10.  Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.

Authors:  Feng Sun; Qiaoling Ruan; Jiali Wang; Shu Chen; Jialin Jin; Lingyun Shao; Ying Zhang; Wenhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.